Otsuka Holdings Co., Ltd. (TYO:4578)
11,905
+135 (1.15%)
Nov 4, 2026, 3:30 PM JST
Otsuka Holdings Revenue
Otsuka Holdings had revenue of 710.05B JPY in the quarter ending September 30, 2026, with 11.30% growth. This brings the company's total for the last twelve months to 2.69T, up 11.33% year-over-year. In the year 2025, Otsuka Holdings had annual revenue of 2.47T with 5.97% growth. That makes Otsuka Holdings the 893rd largest company in the world by revenue and 81st in Japan.
Revenue (ttm)
2.69T
Revenue Growth
+11.33%
P/S Ratio
2.29
Revenue / Employee
71.31M
Employees
37,758
Market Cap
6.24T
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Otsuka Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47T | 139.03B | 5.97% |
| Dec 31, 2024 | 2.33T | 311.29B | 15.42% |
| Dec 31, 2023 | 2.02T | 280.57B | 16.14% |
| Dec 31, 2022 | 1.74T | 239.72B | 16.00% |
| Dec 31, 2021 | 1.50T | 75.45B | 5.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.69T |
| Daiichi Sankyo Company | 2.31T |
| Astellas Pharma | 2.27T |
| Chugai Pharmaceutical | 1.41T |
| Terumo | 1.18T |
| Olympus | 1.04T |
| HOYA Corporation | 1.01T |
| Eisai | 857.06B |
Otsuka Holdings News
- 5 days ago - Otsuka Holdings Quarterly report: Q3 2026 - Filings
- 5 days ago - Otsuka Holdings Slides: Q3 2026 - Filings
- 6 weeks ago - Ionis announces Phase 3 FUSION study of ulefnersen met primary endpoint - TheFly
- 3 months ago - Otsuka Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Otsuka Holdings Slides: Q2 2026 - Filings
- 3 months ago - Otsuka Holdings Quarterly report: Q2 2026 - Filings
- 5 months ago - Otsuka says kidney disease drug preserves function in late-stage study - Reuters
- 6 months ago - Otsuka Holdings Quarterly report: Q1 2026 - Filings